American Cryostem (American Cryostem) EV-to-Revenue : -5.15 (As of Apr. 26, 2024)

View and export this data going back to 2010. Start your Free Trial

What is American Cryostem EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, American Cryostem's enterprise value is $1.17 Mil. American Cryostem's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.23 Mil. Therefore, American Cryostem's EV-to-Revenue for today is -5.15.

The historical rank and industry rank for American Cryostem's EV-to-Revenue or its related term are showing as below:

CRYO's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.68
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-26), American Cryostem's stock price is $0.0001. American Cryostem's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.00. Therefore, American Cryostem's PS Ratio for today is .

American Cryostem EV-to-Revenue Historical Data

The historical data trend for American Cryostem's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem EV-to-Revenue Chart

American Cryostem Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

EV-to-Revenue

Get a 7-Day Free Trial

24.63

32.98

58.25

40.60

931.21

American Cryostem Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
EV-to-Revenue	Get a 7-Day Free Trial															31.73	931.21	-699.74	-142.40	-65.48

Competitive Comparison of American Cryostem's EV-to-Revenue

For the Biotechnology subindustry, American Cryostem's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Cryostem's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Cryostem's EV-to-Revenue falls into.

American Cryostem EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

American Cryostem's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1.170	/	-0.227
	=	-5.15

American Cryostem's current Enterprise Value is $1.17 Mil.
American Cryostem's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

American Cryostem (OTCPK:CRYO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

American Cryostem's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0001	/	-0.003
	=

American Cryostem's share price for today is $0.0001.
American Cryostem's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

American Cryostem EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Cryostem's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cryostem (American Cryostem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724

Website

http://www.americancryostem.com

American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.

Executives

John S Arnone	director, officer: Chairman	111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski	director, officer: COO	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc.	10 percent owner	188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill	10 percent owner	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina	director, 10 percent owner, officer: President and Director	1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915